SMTI Logo

Sanara MedTech Inc. (SMTI) 

NASDAQ
Market Cap
$322.55M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
714 of 774
Rank in Industry
47 of 48

Largest Insider Buys in Sector

SMTI Stock Price History Chart

SMTI Stock Performance

About Sanara MedTech Inc.

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps …

Insider Activity of Sanara MedTech Inc.

Over the last 12 months, insiders at Sanara MedTech Inc. have bought $0 and sold $0 worth of Sanara MedTech Inc. stock.

On average, over the past 5 years, insiders at Sanara MedTech Inc. have bought $0 and sold $124,297 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,927,712 shares for transaction amount of $16M was made by Nixon Ronald T () on 2019‑10‑15.

List of Insider Buy and Sell Transactions, Sanara MedTech Inc.

2022-11-08SaleChief Executive Officer
417
0.0053%
$33.00$13,761+19.97%
2022-11-04SaleChief Executive Officer
563
0.0071%
$33.00$18,579+20.33%
2022-11-02SaleChief Executive Officer
20
0.0003%
$33.02$660+32.08%
2022-09-22SalePres. - Strategic Partnerships
1,000
0.0117%
$27.89$27,887+34.55%
2022-07-05SaleChief Executive Officer
750
0.0099%
$23.00$17,250+76.24%
2022-06-28SaleChief Executive Officer
294
0.0039%
$21.00$6,174+82.69%
2022-06-24SaleChief Executive Officer
457
0.0059%
$21.00$9,597+77.16%
2022-06-17SalePres. - Strategic Partnerships
1,000
0.013%
$20.02$20,020+86.86%
2021-10-26SalePresident - Surgical Div.
1,000
0.0128%
$34.04$34,040-24.58%
2021-10-20SalePresident - Wound Care Div.
1,000
0.0133%
$34.19$34,191-21.82%
2021-10-05SalePresident - Surgical Div.
1,000
0.0128%
$33.10$33,104-22.17%
2021-09-28SalePresident - Wound Care Div.
1,000
0.0131%
$33.33$33,330-20.62%
2019-10-15Purchase
1.93M
25.6795%
$8.30$16M+50.00%
2019-10-15Purchase
361,446
4.8149%
$8.30$3M+50.00%
2019-10-15Purchase
120,482
1.605%
$8.30$1M+50.00%
2015-07-31Purchase
1,786
1.2257%
$69.99$125,000-30.00%
2015-07-31Purchase
1,786
$69.99$125,000-30.00%
2013-12-19Purchasedirector
1,723
$0$0+11.11%
2013-11-12PurchaseCEO
3,257
$0$0+42.86%
2012-12-23Saledirector
8,877
0.7705%
$3.00$26,631

Insider Historical Profitability

50%
COSSUTTA ARALDO Adirector
5259214
60.1661%
$36.9025
HAIRE SCOTT APresident & CEO
4646403
53.1555%
$36.9020
EVANS STEVE W
1348333
15.4251%
$36.9010
Nixon Ronald T
963856
11.0266%
$36.9010+50%
STUCKERT JAMES W
814830
9.3218%
$36.9020+50%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$90.46M104.889.05M+4,318.25%+$88.41M<0.01
State Street$63.7M73.866.37M+11,829.37%+$63.17M<0.01
Geode Capital Management$24.17M28.022.42M+7.22%+$1.63M<0.01
Boxer Capital, LLC$15.45M17.911.54MNew+$15.45M0.32
Duquesne Family Office Llc$9.84M11.41984,000New+$9.84M0.27
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.